Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer

HOPAYA is a monocentric open-label clinical research with 2 parallel groups. Patients will be 1:1 randomly assigned in both groups.

The main objective of the study is to compare the evolution of the health-related quality of life of former patients who have benefited of a multidisciplinary day hospitalization to those who only had standard oncological follow-up during the first year after cancer treatment completion.

The secondary objectives are:

* to evaluate and compare the anxiety and depression level in both groups (with or without day hospitalization); * to evaluate emotional competence in both groups (with or without day hospitalization); * to evaluate the satisfaction about the multidisciplinary day hospitalization.

This study will be presented to patients (and their parents/legal tutors in case of minor patients) during the last visit for any treatment, by coordinating nurses of AYA Department and/or by the adult or pediatric oncologist. At the same time, the information sheet with the consent form will be provided in order to give them a reasonable time for reflection.

After the collection of the consent form for the conduct of the study, former patients will be randomly assigned in 2 groups, with or without multidisciplinary day hospitalization.

• Group A : former patients with multidisciplinary day hospitalization In this group, a multidisciplinary day hospitalization will be programmed after the end-of-treatment evaluation and 2 months after the end of treatment at the latest. This day hospitalization will consist at least of a psychological interview, an interview with a social worker and a medical interview. The medical interview will be conducted by a clinician researcher, specialised in long-term care after cancer. The objectives of this medical interview are to summarize the pathology, the treatment(s) received, and to develop a personalized after-cancer plan. The doctor will carry out both a clinical and an overall assessment of the patient, by wide-ranging questioning covering educational/professional, social, dietetic, addictology and physical fields. This medical interview is complementary to oncological follow-up, which consists of monitoring relapse and possible sequelae.

The psychological interview will be carried out if possible by the psychologist who followed the former patient during his/her treatment. The psychologist will assess the needs for further care, and will refer the former patient if necessary.

The social interview will be carried out by the social worker of AYA department. The social worker will take stock of the former patient's return to school and/or professional life, and direct him/her to possible applications for social assistance if needed.

If needs of supportive care emerge from the history of treatment period, some consultations can be added during the day hospitalization, like an interview with a dietician or an adapted physical activity assessment.

• Group B : former patients without multidisciplinary day hospitalization In this group, the former patients will experiment the standard of care, with an oncological follow-up.

The investigators expect that the AYAs' participation to the hospitalization day will positively impact their health-related quality of life compared to those who haven't participated. The investigators also expect that emotional competence will be explicative of the HRQoL through the mediation of the anxiety and depression levels.

Through the development of a multidisciplinary end-of-treatment day hospitalization, health care professionals plan to improve the quality of life of former patients during this transition phase of completing treatment. The lack of information on both medical and psychosocial long-term effects, will be improved by early and specific support. The feeling of abandonment often felt by former patients should decrease.

In addition, the early introduction of the long-term follow-up physician in the management of post-cancer, in parallel with the former patient's referring oncologist, should increase information and adherence to the personalized post-cancer plan.

The HOPAYA study aims to improve knowledge about the immediate quality of life after the treatment of AYAs with cancer, which is a challenge in this vulnerable population with specific needs. Comparison with the control group will make possible to highlight the specific impact of the establishment of a multidisciplinary end-of-treatment day hospitalization on quality of life. It will allow to target the flaws and shortcomings in AYA survivors support. The investigators also expect that the early screening of emotional competence will allow health care professionals to tailor support to the special needs of AYAs and their families.

Although many recommendations have emerged from the literature, to our knowledge, very few devices such this multidisciplinary day hospital have been elaborated for AYA early survivors of cancer. This study will evaluate the feasibility and the acceptability of a specific end-of-treatment hospitalization day for AYAs. The data collected and the analysed results in this study will allow to adapt and generalize this device in all AYAs' survivors in the CLB, and then at a larger level.

This study will lead to a scientific article published in an international journal, allowing the AYA hospitalization day to be reproduced in other oncologic centres and hospitals.

• To evaluate and compare the evolution of health-related quality of life at 12 months in the 2 groups [Time frame: from 0 to 3 months after the end of the treatments, and at 12 months after cancer treatment completion]
• To evaluate and compare the evolution of QOL over time in the two groups: longitudinal analysis [Time frame: at inclusion (0 to 3 months after the end of treatment), and at 3, 6, 9 and 12 months after cancer treatment completion]
• To evaluate and compare the level of anxiety and depression in the 2 groups at inclusion (0 to 3 months after the end of treatment) and at 12 months [Time frame: at inclusion (0 to 3 months after the end of treatment) and at 12 months after cancer treatment completion]
• To evaluate and compare the emotional regulation difficulties of the AYAs in the 2 groups at inclusion (0 to 3 months after the end of treatment) and at 12 months [Time frame: at inclusion (0 to 3 months after the end of treatment) and at 12 months after cancer treatment completion]
• To describe the compliance of the AJAs to the multidisciplinary DH vs. to the standard oncological follow-up without multidisciplinary DH, and to the proposed medical and paramedical orientations [Time frame: 12 months after cancer treatment completion]
• To describe the sequelae of the AJA in the 2 groups at inclusion (0 to 3 months after the end of treatment) and at 12 months [Time frame: at inclusion (0 to 3 months after the end of treatment) and at 12 months after cancer treatment completion]
• To evaluate the satisfaction of the AJAs who participate in the multidisciplinary DH following it [Time frame: Immediately after the multidisciplinary DH]